J Lortet-Tieulent1, I Soerjomataram1, J Ferlay1, M Rutherford2, E Weiderpass3, F Bray4. 1. Section of Cancer Information, International Agency for Research on Cancer, Lyon, France. 2. Department of Health Sciences, University of Leicester, Leicester, UK. 3. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Research, Cancer Registry of Norway, Oslo, Norway; Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway; Samfundet Folkhälsan, Helsinki, Finland. 4. Section of Cancer Information, International Agency for Research on Cancer, Lyon, France. Electronic address: brayf@iarc.fr.
Abstract
OBJECTIVES: Trends in overall lung cancer incidence in different countries reflect the maturity of the smoking epidemic. Further understanding of the underlying causes for trends over time can be gained by assessing the trends by sex and histological subtype. We provide a temporal analysis of lung cancer incidence in 12 populations (11 countries), with a focus on cohort-specific trends for the main histological subtypes (squamous cell carcinomas (SCC), adenocarcinomas (AdC), and small cell carcinoma). MATERIAL AND METHODS: We restrict the analysis to population-based registry data of sufficient quality to provide meaningful interpretation, using data in Europe, North America and Oceania, extracted from successive Cancer Incidence in Five Continents Volumes. Poorly specified morphologies were reallocated to a specified grouping on a population, 5-year period and age group basis. RESULTS: In men, lung cancer rates have been declining overall and by subtype, since the beginning of the study period, except for AdC. AdC incidence rates have risen and surpassed those of SCC (historically the most frequent subtype) in the majority of these populations, but started to stabilize during the mid-1980s in North America, Australia and Iceland. In women, AdC has been historically the most frequent subtype and rates continue to increase in most populations studied. Early signs of a decline in AdC can however be observed in Canada, Denmark and Australia among very recent female cohorts, born after 1950. CONCLUSIONS: The continuing rise in lung cancer among women in many countries reinforces the need for targeted smoking cessation efforts alongside preventive actions.
OBJECTIVES: Trends in overall lung cancer incidence in different countries reflect the maturity of the smoking epidemic. Further understanding of the underlying causes for trends over time can be gained by assessing the trends by sex and histological subtype. We provide a temporal analysis of lung cancer incidence in 12 populations (11 countries), with a focus on cohort-specific trends for the main histological subtypes (squamous cell carcinomas (SCC), adenocarcinomas (AdC), and small cell carcinoma). MATERIAL AND METHODS: We restrict the analysis to population-based registry data of sufficient quality to provide meaningful interpretation, using data in Europe, North America and Oceania, extracted from successive Cancer Incidence in Five Continents Volumes. Poorly specified morphologies were reallocated to a specified grouping on a population, 5-year period and age group basis. RESULTS: In men, lung cancer rates have been declining overall and by subtype, since the beginning of the study period, except for AdC. AdC incidence rates have risen and surpassed those of SCC (historically the most frequent subtype) in the majority of these populations, but started to stabilize during the mid-1980s in North America, Australia and Iceland. In women, AdC has been historically the most frequent subtype and rates continue to increase in most populations studied. Early signs of a decline in AdC can however be observed in Canada, Denmark and Australia among very recent female cohorts, born after 1950. CONCLUSIONS: The continuing rise in lung cancer among women in many countries reinforces the need for targeted smoking cessation efforts alongside preventive actions.
Authors: Jenny T Mao; Qing-Yi Lu; Bingye Xue; Patricia Neis; Felix D Zamora; Laurie Lundmark; Clifford Qualls; Larry Massie Journal: Cancer Prev Res (Phila) Date: 2019-05-28
Authors: Catherine C Lerro; Jonathan N Hofmann; Gabriella Andreotti; Stella Koutros; Christine G Parks; Aaron Blair; Paul S Albert; Jay H Lubin; Dale P Sandler; Laura E Beane Freeman Journal: Int J Epidemiol Date: 2020-08-01 Impact factor: 7.196
Authors: Guilherme Jorge Costa; Maria Júlia Gonçalves de Mello; Carlos Gil Ferreira; Luiz Claudio Santos Thuler Journal: J Cancer Res Clin Oncol Date: 2017-04-07 Impact factor: 4.553
Authors: Soumaya Ben Khedher; Monica Neri; Alexandra Papadopoulos; David C Christiani; Nancy Diao; Curtis C Harris; Susan Olivo-Marston; Ann G Schwartz; Michele Cote; Anita Koushik; Jack Siemiatycki; Maria Teresa Landi; Rayjean J Hung; John McLaughlin; Eric J Duell; Angeline S Andrew; Irene Orlow; Bernard J Park; Hermann Brenner; Kai-Uwe Saum; Angela C Pesatori; Isabelle Stücker Journal: Int J Cancer Date: 2017-05-10 Impact factor: 7.396